Table 1 Baseline clinical characteristics by the 4 phenotype groups.

From: Relationship between fatty pancreas and hypertriglyceridemic waist phenotype: a cross-sectional study

 

Total

G-1

G-2

G-3

G-4

Pa

N

1241

538

134

290

279

 

Male

581/46.8

220/40.9

97/72.4*

104/35.9*‡

160/57.3*&

< 0.001

Age

45.7 ± 14.1

41.0 ± 13.5

46.1 ± 12.1*

48.9 ± 14.0*

51.2 ± 13.6*‡

< 0.001

BMI

23.9 ± 3.5

21.6 ± 2.3

23.2 ± 2.2*

26.0 ± 3.0*‡

26.8 ± 2.9*‡&

< 0.001

WC

83.5 ± 10.7

75.2 ± 6.7

81.8 ± 6.4*

90.2 ± 7.9*‡

93.6 ± 7.3*‡&

< 0.001

Smoking

247/19.9

85/15.8

38/28.4*

46/15.9‡

78/28.0*‡&

< 0.001

Drinking

247/19.9

72/13.4

45/33.6*

44/15.2‡

86/30.8*‡&

< 0.001

MetS

307/24.7

0/0

28/20.9*

44/15.2*

235/84.2*‡&

< 0.001

HBP

98/7.9

13/2.4

8/6.0*

33/11.4*

44/15.8*&

< 0.001

T2DM

10/0.8

3/0.6

0/0

3/1.0

4/1.4

0.381

FL

366/29.5

43/8.0

44/32.8*

99/34.1*

180/64.5*‡&

< 0.001

FP

53/4.3

3/0.6

2/1.5

19/6.6*‡

29/10.4*‡&

< 0.001

  1. Values are expressed as means (standard deviation) or n/%
  2. G-1 (group-1): normal waist-normal triglyceride; G-2 (group-2): normal waist-elevated triglycerides; G-3 (group-3): elevated waist-normal triglycerides; G-4 (group-4): elevated waist-elevated triglyceride (HTGW).
  3. BMI body mass index, HBP high blood pressure, MetS metabolic syndrome, T2DM type 2 diabetes mellitus, FP fatty pancreas, FL fatty live, WC waist circumference.
  4. aComparison among three groups.
  5. *Compared with G-1, P < 0.05.
  6. ‡Compared with G-2, P < 0.05.
  7. &Compared with G-3, P < 0.05.
Back to article page